Background

The contaminated blood scandal

In the 1970s and 1980s around 5,000 people with haemophilia and other bleeding disorders were infected with HIV and hepatitis viruses through the use of contaminated clotting factors. Since then more than 3,000 people have died and of the 1,200 people infected with HIV less than 250 are still alive.

Living with a bleeding disorder

People with bleeding disorders lack a protein that enables their blood to clot, most commonly factor VIII. This means even minor injuries can lead to bleeding that is difficult to treat.

Until the 1970s the treatment for these disorders required transfusions with plasma which had to be given in hospital.

This treatment was replaced with a revolutionary new product, factor concentrate, which could be administered at home with an injection. For the first time, people with bleeding disorders could be treated prior to a bleed (prophylactically) reducing the likelihood of a bleed and the resulting joint damage.

Factor concentrate: the deadly risks

Factor concentrate was produced by pooling human blood plasma from up to 40,000 donors and concentrating it to extract the required factor. Just one contaminated sample could infect the entire batch.

Blood and blood products were known to transfer viruses such as hepatitis, so the use of pooled blood products increased the risk of infection significantly.

The danger of contamination rose further when a shortage of UK-produced factor concentrate meant it was imported from the United States, which used blood from high-risk paid donors, such as prisoners and drug addicts.

Ignoring the risks

These risks were ignored by leading clinicians and Government who failed to take appropriate action to end their use and return to safer products. Pharmaceutical companies and leading clinicians did not share appropriate information about risks with patients and patient groups.

In 1975 the then Health Minster, Dr David Owen, announced that funds had been allocated to ensure the UK became ‘self-sufficient’ in blood products, but this never happened. From this time outbreaks of hepatitis began to be reported from haemophilia centres around the country.

In 1982 the first death of a man with haemophilia infected by AIDS was reported in the US and the first warning of the danger of contracting AIDS from contaminated blood products was published in the US. This was followed in 1983 by other warnings, in the Lancet and from the World Health Organisation which said that people with haemophilia should be warned of the dangers.

The Haemophilia Society

During this period The Haemophilia Society issued statements reassuring people with bleeding disorders that the new factor treatments were safe and to continue using them.

The advice we gave our members was based on guidance from the Haemophilia Centre Directors (now known as the UKHCDO) and from the Government. We accept that our actions and statements at the time, while well intentioned and based on expert advice, have subsequently been shown to be damaging to the community and false. For this, we have apologised unreservedly.

Financial support

In 1989 the UK Government announced ex-gratia payments to people infected with HIV through contaminated blood products. In 2004 another fund to make payments to people infected with hepatitis was launched by the Government. A more detailed explanation of the financial support schemes available can be found here as well as a summary of the amounts currently available.

Progress towards safer treatment

By 1984, heat-treated blood products, in which the viruses had been deactivated started to become available, this combined with improvements in donor vetting, meant that by 1986 UK patients were receiving safer treatment, although some risks remained.

Late in the 1990s the use of synthetic (known as recombinant) clotting factors started to become widespread in the UK effectively eliminating the risks from viruses and other contaminants.

The Infected Blood Public Inquiry and beyond

Prime Minister Theresa May announced that a statutory public inquiry would be held into the contaminated blood scandal in 2017.

Since that announcement, more than 100 people infected and affected by the scandal have died. More will die before the inquiry reaches its conclusions. This is a tragedy which continues to take and devastate lives.

The Haemophilia Society has been campaigning for a public inquiry since 1988. We welcome scrutiny of our role, as well as that of all other organisations involved. We hope this Inquiry will finally deliver closure, justice and recognition of what has happened and the suffering it has caused.

  • Recent News